Neurotransmitter

• News Feature: Cannabis and the adolescent brain (24 Sep 2024)
  
• Cannabinoids and monoaminergic system: implications for learning and memory (03 Sep 2024)
  
• Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine (02 Sep 2024)
  
• Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson’s Disease (02 Sep 2024)
  
• The Relationship between Muscarinic and Cannabinoid Receptors in Neuronal Excitability and Epilepsy: A Review (02 Sep 2024)
  
• Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease (02 Sep 2024)
  
• Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease (27 Aug 2024)
  
• Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies (25 Aug 2024)
  
• Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex (25 Aug 2024)
  
• Cannabinoid signaling and risk in Huntington's disease (25 Aug 2024)
  
• Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study (25 Aug 2024)
  
• The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss (18 Aug 2024)
  
• Effect of interaction between acute administration of morphine and cannabinoid compounds on spontaneous excitatory and inhibitory postsynaptic currents of magnocellular neurons of supraoptic nucleus (18 Aug 2024)
  
• Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System (18 Aug 2024)
  
• The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (12 Aug 2024)
  
• Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review (27 Feb 2023)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies (27 Aug 2022)
  
• Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
  
• New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence (27 Aug 2022)
  
• Enhancing Endocannabinoid Control of Stress with Cannabidiol (27 Aug 2022)
  
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
  
• Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)
  
• Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option? (05 Aug 2022)
  
• Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
  
• Endocannabinoid System and Migraine Pain: An Update (25 Jul 2022)
  
• Coffee & Cannabis (21 Jul 2022)
  
• CBD & the Psychedelic Receptor (21 Jul 2022)
  
• Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (20 Jul 2022)